{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:28:40Z","timestamp":1785785320402,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.lanepe.2026.101719","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:54:43Z","timestamp":1780358083000},"page":"101719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Real-World Psilocybin Therapy for Treatment-Resistant Depression: A Retrospective Observational Study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8142-5874","authenticated-orcid":false,"given":"Johannes","family":"Jungwirth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Westenh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena D.","family":"Aicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Provaznikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golo","family":"Kronenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Seifritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Prinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Olbrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2026.101719_bib1","series-title":"Global Burden of Disease Study 2021 (GBD 2021) results Depressive Disorders Prevalence 2021","year":"2024"},{"key":"10.1016\/j.lanepe.2026.101719_bib2","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Ferrari","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.lanepe.2026.101719_bib3","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR\u2217D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.lanepe.2026.101719_bib4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.lanepe.2026.101719_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2025.1588902","article-title":"Editorial: treatment resistant depression (TRD): epidemiology, clinic, burden and treatment","volume":"16","author":"Fiorillo","year":"2025","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.lanepe.2026.101719_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12888-019-2222-4","article-title":"The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study","volume":"19","author":"Jaffe","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.lanepe.2026.101719_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211006508","article-title":"Excess deaths in treatment-resistant depression","volume":"11","author":"Brenner","year":"2021","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.lanepe.2026.101719_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.lanepe.2026.101719_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/02698811241312866","article-title":"Catalyst for change: psilocybin's antidepressant mechanisms\u2014A systematic review","volume":"39","author":"Liebnau","year":"2025","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.lanepe.2026.101719_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078084","article-title":"Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis","volume":"385","author":"Metaxa","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.lanepe.2026.101719_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00115-024-01727-0","article-title":"Psychedelika und Dissoziativa in der Psychiatrie: herausforderungen in der Behandlung","volume":"95","author":"Jungwirth","year":"2024","journal-title":"Nervenarzt"},{"key":"10.1016\/j.lanepe.2026.101719_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/02698811231180276","article-title":"Risk of bias in randomized clinical trials on psychedelic medicine: a systematic review","volume":"37","author":"Hovmand","year":"2023","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.lanepe.2026.101719_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.24119","article-title":"Control group outcomes in trials of psilocybin, SSRIs, or esketamine for depression","volume":"8","author":"Hieronymus","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lanepe.2026.101719_bib14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-Dose psilocybin treatment for major depressive disorder a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.lanepe.2026.101719_bib15","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-Dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanepe.2026.101719_bib16","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.lanepe.2026.101719_bib17","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.24m15449","article-title":"Results from a long-term observational follow-up study of a single dose of psilocybin for a treatment-resistant episode of major depressive disorder","volume":"86","author":"Goodwin","year":"2025","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.lanepe.2026.101719_bib18","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3390\/jcm11040938","article-title":"Trajectory of antidepressant effects after single- or two-dose administration of psilocybin: a systematic review and multivariate meta-analysis","volume":"11","author":"Yu","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.lanepe.2026.101719_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.medj.2024.01.005","article-title":"Psilocybin-assisted psychotherapy for treatment resistant depression: a randomized clinical trial evaluating repeated doses of psilocybin","volume":"5","author":"Rosenblat","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.lanepe.2026.101719_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.nsa.2025.105525","article-title":"Implementing psychedelic-assisted therapy: history and characteristics of the Swiss limited medical use program","volume":"4","author":"Liechti","year":"2025","journal-title":"Neurosci Appl"},{"key":"10.1016\/j.lanepe.2026.101719_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00278-024-00711-y","article-title":"Psychedelika-assistierte psychotherapie","volume":"69","author":"Aicher","year":"2024","journal-title":"Psychotherapie"},{"key":"10.1016\/j.lanepe.2026.101719_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66817-0","article-title":"Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy","volume":"14","author":"de la Salle","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.lanepe.2026.101719_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/02698811241278873","article-title":"Naturalistic psychedelic therapy: the role of relaxation and subjective drug effects in antidepressant response","volume":"38","author":"Calder","year":"2024","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.lanepe.2026.101719_bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00115-006-2098-7","article-title":"Reliabilit\u00e4t und validit\u00e4t des revidierten Beck- Depressionsinventars (BDI-II). Befunde aus deutschsprachigen stichproben","volume":"78","author":"K\u00fchner","year":"2007","journal-title":"Nervenarzt"},{"key":"10.1016\/j.lanepe.2026.101719_bib26","first-page":"51","article-title":"[Studies of the reliability and validity of the German version of the Montgomery-Asberg Depression Rating Scale (MADRS)]","volume":"139","author":"Schmidtke","year":"1988","journal-title":"Schweiz Arch Neurol Psychiatr (1985)"},{"key":"10.1016\/j.lanepe.2026.101719_bib27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","article-title":"Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs","volume":"4","author":"Lakens","year":"2013","journal-title":"Front Psychol"},{"key":"10.1016\/j.lanepe.2026.101719_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"key":"10.1016\/j.lanepe.2026.101719_bib29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/brainsci14080829","article-title":"Comparison between single-dose and two-dose Psilocybin administration in the treatment of major depression: a systematic review and meta-analysis of current clinical trials","volume":"14","author":"Salvetti","year":"2024","journal-title":"Brain Sci"},{"key":"10.1016\/j.lanepe.2026.101719_bib30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.lanepe.2026.101719_bib31","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of Psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanepe.2026.101719_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.euroneuro.2023.10.002","article-title":"The never-ending problem: sample size matters","volume":"79","author":"De Prisco","year":"2024","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.lanepe.2026.101719_bib33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/02698811231179910","article-title":"Attenuation of psilocybin mushroom effects during and after SSRI\/SNRI antidepressant use","volume":"37","author":"Gukasyan","year":"2023","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.lanepe.2026.101719_bib34","article-title":"Current perspectives on psychedelic treatments in Europe","volume":"61","author":"Madero","year":"2026","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanepe.2026.101719_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.euroneuro.2025.01.004","article-title":"Classical psychedelics in therapy: essential psychotherapy or minimal support?","volume":"93","author":"Knudsen","year":"2025","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226001316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226001316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T08:27:37Z","timestamp":1785745657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776226001316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":34,"alternative-id":["S2666776226001316"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101719","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Psilocybin Therapy for Treatment-Resistant Depression: A Retrospective Observational Study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101719"}}